Top Back to top

Global Committee

EBMT Global Committee Frankfurt 2019
EBMT Global Committee - EBMT Annual Meeting 2019, Frankfurt, Germany

The EBMT Global committee (EGC) was created by the EBMT Board in October 2017 to further extend the scope of stem cell transplantation and cell therapy to as many transplant teams as possible outside Europe to extend further our common knowledge, medical training and research.

The EGC was first constituted in Lisbon during the EBMT Annual Meeting in March 2018 with 16 members, including 6 colleagues from China, 1 from Taiwan, 2 from Korea, one from Vietnam, two from Latin America (Argentina and Brazil), 1 from Lebanon, 1 from Saudi Arabia. We met again in March 2019 at the EBMT Annual Meeting in Frankfurt.

Global Committee Team

Committee Objectives

  • Promote the EBMT mission outside Europe, starting with Asia, i.e. particularly China, India, Korea, Vietnam.
  • Increase European knowledge from this experience thus far not included in the EBMT megafile, and likewise share the European experience with new joining team members.
  • Increase the recruitment of EBMT teams and the numbers of transplants reported to the Registry.
  • Enlarge the database.
  • Translate into all languages (Mandarin in China, as an example) the items in use in the EBMT collection and analysis software.
  • Promote comparisons of transplant methodologies.
  • Reactivate centre effect studies that would benefit from the addition of new teams with different therapeutic approaches.
  • Expand targets for educational meetings.  
  • Promote EBMT and its member teams (current and new members) through joint scientific meetings.
  • Increase the exchanges with young investigators and PI for retrospective studies.
  • Promote the exchange of nurses specialised in stem cell transplantation.
  • Propose JACIE program worldwide.

Activities

  • Organisation of the Global Committee annual or biannual meeting with worldwide members of the committee to define actions, policy and evaluate results of previous actions.
  • Monitoring of membership outside Europe, and specifically in Asia.
  • Ensure compatibility between registries (EBMT and national registries)
  • Further the development of joint meetings bringing together European and non-European teams, with a specific focus in 2018 on Asian and Latin American teams
  • Annual report to the Board

Strategy

In view of the growing cooperation between many Chinese and European teams and also in view of our 2018 congress in Lisbon with a record participation from Latin America, the EBMT Global Committee has decided to focus first on Asia and Latin America.

EBMT aims to federate all transplant teams willing to share and increase experience in cell therapy today and tomorrow.

Activity Report 2021

Despite the COVID pandemics that has considerably restrained presential activity, the EBMT Global Committee (EGC) during the past year has achieved some major objectives.

Global Committee renewal

The EGC has been renewed for two years. Most members of the first EGC have expressed their wish to remain on board. Please check the Global Committee Team at the top.

If you wish to join our team, please contact us. Note that two sponsors are needed. In case of difficulties to find a sponsor, the EGC committee suggests for applicants to join any EGC member (especially if there is one in their own country) and/or to request their application to be forwarded for special evaluation to the EGC chair.

EBMT China Office in Shanghai

With the help of the EBMT board, the Chinese Society of Hematology and the Boxiao Society/foundation (President Mr ZhengYi), the EBMT CHINA office has been officially created in Shanghai on December 2020 with a legal ceremony online with the presence of official representatives of the department of sciences and technologies of the townhall of Shanghai.

The localization has been offered for free by the Boxiao society/Foundation in the heart of Shanghai with a facility that includes a meeting room and available videoconferencing.

Legal documents have been processed all over the year 2021 and as it stands now, the governing body consists of Pr Nicolaus Kroeger (EBMT President), Pr Norbert Claude Gorin (EGC Chair) for EBMT, Pr Wu Depei in Suzhou (President Chinese Society of Hematology) and Pr Huang He in Hangzhou (Dean of the First Affiliated Hospital and Director of Hematology Institution Zhejiang University School of Medicine.) for China.

The scientific structure is under the supervision of Pr Norbert Claude Gorin, principal senior investigator (PI) for EBMT, assisted of two executive Chinese co-PI: Dr Chen Jia from Suzhou and Dr Yishan Ye from Hangzhou. Mr Ban Zheng, localized in Paris, greatly facilitates the logistic of scientific affairs and Eva Yu (Boxiao) kindly ensures the administrative work of the structure in Shanghai in liaison with the EBMT office in Barcelona. Two retrospective EBMT-CHINA studies have already been launched.

Monthly online meetings have taken place since then to ensure completion of the administrative tasks as well as parallel monthly meetings devoted to clinical research.

A first EBMT-CHINA inaugural scientific forum was planned to take place in Shanghai on November 19th co-organized by EBMT and the national research center for translational medicine in Ruijin hospital. It was to be a hybrid meeting with Chinese speakers and participants locally present and EBMT speakers online. By November 16th all EBMT participants had prerecorded their talks, when unfortunately, because of the new COVID19 pandemic burst in China, the Chinese authorities decided to cancel meetings in Shanghai. We hope this first forum will be rescheduled in 2022.

Already an application has been received by EBMT to host the second EBMT CHINA forum in Tianjin.

Eighteen new Chinese teams have so far applied to become EBMT team members and their applications have been successfully reviewed so that they are at the moment provisional members to be definitively approved following the decision of the EBMT General Assembly during the Annual Meeting 2022 in Prague.

The table below shows the list of the Chinese applicants at time of writing this report:

CIC Centre Name City Principal Investigator
1008 Institute of Hematology, Chinese Academy of Medical Sciences Tianjin Erlie Jiang
1012 Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai Jiong HU
1013 Central South University, Xiangya Hospital Changsha Yajing XU
1014 Union Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan Yu HU
1015 Shenzhen Children's Hospital Shenzhen Sixi LIU
1016 The First Affiliated Hospital of Xi'an Jiaotong University Xi'an Pengcheng HE
1017 Xinqiao Hospital of Army Medical University Chongqing Xi ZHANG
1018 Tongji Hospital Affiliated to Tongji Univerisity Shanghai Aibin LIANG
1023 First Affiliated Hospital of Sun Yat-sen University Guangzhou Juan LI
1024 Lanzhou University Second Hospital Lanzhou Liansheng ZHANG
1025 First Affiliated Hospital of Xinjiang Medical University Urumqi Ming JIANG
1026 Second Affiliated Hospital of Xi'an Jiaotong University Xi'an Aili HE
1027 First Affiliated Hospital of Zhengzhou University Zhengzhou Yufeng LIU
1028 920th Hospital of Joint Logistics Support Force Kunming Sanbin WANG
1029 Beijing Friendship Hospital, Capital Medical University Beijing Zhao WANG
1030 The First Affiliated Hospital of Wenzhou Medical Unviersity Wenzhou Kang YU
1031 Nanfang Hospital, Southern Medical University Guangzhou Qifa LIU
1032 First Affiliated Hospital of Zhejiang Chinese Medical University Hangzhou Baodong YE

EBMT China Office in Shanghai

Special scientific session and next meeting

In the past three years, the ECG has organized a special scientific session at the EBMT Annual Meeting.

During the 48th EBMT Annual Meeting 2022 in Prague, the ECG has organized a session entitled: “GLOBAL PERSPECTIVE FOR CELLULAR IMMUNE THERAPY” with 5 speakers including 4 of them from Asia. This session is a fully pre-recorded session (available on-demand on the congress platform and also on the On-demand Library).

The next EGC meeting will take place during the EBMT Annual Meeting 2022 in Prague.

Latin America

Stem cell transplantation and cell therapy are taking off in Latin America. EGC has designated Latin America as its next recruitment effort to come, with the help of EGC Latin America members.